New drug trial aims to put the brakes on Alzheimer's
NCT ID NCT04804241
Summary
This study is testing an oral drug called Senicapoc to see if it can slow down the progression of Alzheimer's disease in people with early memory problems. About 55 participants will take either the drug or a placebo daily for one year. Researchers will measure changes in memory, thinking skills, brain scans, and markers of inflammation in the blood and spinal fluid to see if the treatment is working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UC Davis Alzheimer's Disease Center East Bay
RECRUITINGWalnut Creek, California, 94598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California, Davis Alzheimer's Disease Center
RECRUITINGSacramento, California, 95817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.